Biomarkers: Screening for C-reactive protein in CVD prediction

Sanne A.E. Peters*, Frank L.J. Visseren, Diederick E. Grobbee

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Adding C-reactive protein (CRP) level to conventional cardiovascular risk models has been suggested to improve risk prediction for cardiovascular events. However, evaluation of the potential impact of CRP measurement in cardiovascular risk management will require studies designed to quantify the effect of additional CRP assessment on medical decision-making, patient outcomes, and cost-effectiveness.

Original languageEnglish
Pages (from-to)12-14
Number of pages3
JournalNature Reviews Cardiology
Volume10
Issue number1
DOIs
Publication statusPublished - Jan 2013

Keywords

  • Biomarkers
  • C-Reactive Protein
  • Cardiovascular Diseases
  • Decision Support Techniques
  • Humans
  • Inflammation Mediators
  • Mass Screening
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Journal Article

Fingerprint

Dive into the research topics of 'Biomarkers: Screening for C-reactive protein in CVD prediction'. Together they form a unique fingerprint.

Cite this